The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBritish American Tobacco Regulatory News (BATS)

Share Price Information for British American Tobacco (BATS)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 2,351.00
Bid: 2,326.00
Ask: 2,384.00
Change: 0.00 (0.00%)
Spread: 58.00 (2.494%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 2,351.00
BATS Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Holding(s) in Company

6 Aug 2020 14:00

RNS Number : 3975V
British American Tobacco PLC
06 August 2020
 

 

 

 

British American Tobacco p.l.c.

TR-1: Notification of major holdings

 

1a. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attachedii:

British American Tobacco p.l.c.

1b. Please indicate if the issuer is a non-UK issuer (please mark with an "X" if appropriate)

Non-UK issuer

 

2. Reason for the notification (please mark the appropriate box or boxes with an "X")

An acquisition or disposal of voting rights

X

An acquisition or disposal of financial instruments

X

An event changing the breakdown of voting rights

 

Other (please specify)iii:

 

3. Details of person subject to the notification obligationiv

Name

The Capital Group Companies, Inc. ("CGC")

City and country of registered office (if applicable)

Los Angeles, CA 90071, USA

4. Full name of shareholder(s) (if different from 3)v

Name

N/A

City and country of registered office (if applicable)

 

5. Date on which the threshold was crossed or reachedvi:

4 August 2020

6. Date on which issuer notified (DD/MM/YYYY):

6 August 2020

7. Total positions of person(s) subject to the notification obligation

 

% of voting rights attached to shares (total of 8. A)

% of voting rights through financial instruments(total of 8.B 1 + 8.B 2)

Total of both in % (8.A + 8.B)

Total number of voting rights of issuervii

Resulting situation on the date on which threshold was crossed or reached

10.7125%

0.0197%

10.7322%

2,294,230,293

Position of previous notification (if

applicable)

11.9240%

0.0539%

11.9779%

 

       

 

8. Notified details of the resulting situation on the date on which the threshold was crossed or reachedviii

A: Voting rights attached to shares

Class/type ofshares

ISIN code (if possible)

Number of voting rightsix

% of voting rights

Direct

(Art 9 of Directive 2004/109/EC) (DTR5.1)

Indirect

(Art 10 of Directive 2004/109/EC) (DTR5.2.1)

Direct

(Art 9 of Directive 2004/109/EC) (DTR5.1)

Indirect

(Art 10 of Directive 2004/109/EC) (DTR5.2.1)

Ordinary Shares

(ISIN:GB0002875804)

 

218,100,514

 

9.5065%

ADRs

(ISIN:US1104481072)

 

27,669,276

 

1.2060%

 

 

 

 

 

SUBTOTAL 8. A

245,769,790

10.7125%

 

 

B 1: Financial Instruments according to Art. 13(1)(a) of Directive 2004/109/EC (DTR5.3.1.1 (a))

Type of financial instrument

Expirationdatex

Exercise/Conversion Periodxi

Number of voting rights that may be acquired if the instrument is

exercised/converted.

% of voting rights

N/A

 

 

 

 

 

 

SUBTOTAL 8. B 1

 

 

 

 

B 2: Financial Instruments with similar economic effect according to Art. 13(1)(b) of Directive 2004/109/EC (DTR5.3.1.1 (b))

Type of financial instrument

Expirationdatex

Exercise/Conversion Period xi

Physical or cash

settlementxii

Number of voting rights

% of voting rights

Rights to recall lent shares of Depository Receipt

N/A

N/A

Physical settlement

452,906 Depository Receipt shares or 452,906 votes on a converted basis

0.0197%

 

 

 

 

 

 

 

 

 

SUBTOTAL 8.B.2

452,906

0.0197%

 

 

 

          

 

9. Information in relation to the person subject to the notification obligation (please mark the

applicable box with an "X")

Person subject to the notification obligation is not controlled by any natural person or legal entity and does not control any other undertaking(s) holding directly or indirectly an interest in the (underlying) issuerxiii

 

Full chain of controlled undertakings through which the voting rights and/or thefinancial instruments are effectively held starting with the ultimate controlling natural person or legal entityxiv (please add additional rows as necessary)

X

Namexv

% of voting rights if it equals or is higher than the notifiable threshold

% of voting rights through financial instruments if it equals or is higher than the notifiable threshold

Total of both if it equals or is higher than the notifiable threshold

The Capital Group Companies, Inc.

Holdings by CG Management companies are set out below:

10.7125%

0.0000%

10.7322%

Capital Bank & Trust Company2

 

 

 

Capital International, Inc.1

 

 

 

Capital International Limited1

 

 

 

Capital International Sàrl1

 

 

 

• Capital Research and Management Company2

10.4429%

0.0000%

10.4626%

1Indirect subsidiaries of Capital Research and Management Company.

2Subsidiary of The Capital Group Companies, Inc.

 

10. In case of proxy voting, please identify:

Name of the proxy holder

N/A

The number and % of voting rights held

N/A

The date until which the voting rights will be held

N/A

 

11. Additional informationxvi

The Capital Group Companies, Inc. ("CGC") is the parent company of Capital Research and Management Company ("CRMC") and Capital Bank & Trust Company ("CB&T"). CRMC is a U.S.-based investment management company that serves as investment manager to the American Funds family of mutual funds, other pooled investment vehicles, as well as individual and institutional clients. CRMC and its investment manager affiliates manage equity assets for various investment companies through three divisions, Capital Research Global Investors, Capital International Investors and Capital World Investors. CRMC is the parent company of Capital Group International, Inc. ("CGII"), which in turn is the parent company of four investment management companies ("CGII management companies"): Capital International, Inc., Capital International Limited, Capital International Sàrl and Capital International K.K. CGII management companies and CB&T primarily serve as investment managers to institutional and high net worth clients. CB&T is a U.S.-based investment management company that is a registered investment adviser and an affiliated federally chartered bank.

 

Neither CGC nor any of its affiliates own shares of the Issuer for its own account. Rather, the shares reported on this Notification are owned by accounts under the discretionary investment management of one or more of the investment management companies described above.

 

     

 

Place of completion

Los Angeles, CA, USA

Date of completion

5 August 2020

 

 

Name of duly authorised officer of issuer responsible for making notification:

 

R Wilson

Assistant Secretary

British American Tobacco p.l.c.

 

6 August 2020

 

Enquiries:Investor RelationsMike Nightingale/Victoria Buxton/William Houston/John Harney

+44 20 7845 1180/2012/1138/1263

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
HOLPFMBTMTAMBAM
Date   Source Headline
20th Mar 20247:00 amRNSTransaction in Own Shares
19th Mar 20247:00 amRNSTransaction in Own Shares
18th Mar 20247:00 amRNSShare Buy-Back Programme
14th Mar 20248:00 amRNSNotice of AGM
13th Mar 20247:00 amRNSCompletion of Block Trade of ITC Shares
12th Mar 20243:40 pmRNSDirector/PDMR Shareholding
12th Mar 202411:25 amRNSLaunch of Proposed Block Trade of ITC Shares
11th Mar 20244:43 pmRNSResponse to Recent Speculation
11th Mar 20247:00 amRNSBranch Register: Dividend Finalisation Information
7th Mar 20242:20 pmRNSDirector/PDMR Shareholding
5th Mar 20244:30 pmRNSPublication of a Prospectus
4th Mar 20242:15 pmRNSDirector/PDMR Shareholding
1st Mar 202410:45 amRNSDirector/PDMR Shareholding
1st Mar 202410:40 amRNSTotal Voting Rights
21st Feb 202410:45 amRNSDirector/PDMR Shareholding
16th Feb 202411:30 amRNSPricing Notes Offering
15th Feb 20242:55 pmRNSDirector/PDMR Shareholding
13th Feb 20241:30 pmRNSPublication of Suppl.Prospcts
13th Feb 20249:55 amRNSDirector/PDMR Shareholding
9th Feb 20244:17 pmRNSAnnual Financial Report
8th Feb 202412:15 pmRNSDirector/PDMR Shareholding
8th Feb 20247:00 amRNSFinal Results
6th Feb 202410:10 amRNSDirector/PDMR Shareholding
6th Feb 202410:05 amRNSDirector/PDMR Shareholding
6th Feb 20247:00 amRNSBoard and Committee Changes
5th Feb 202412:25 pmRNSDirector/PDMR Shareholding
5th Feb 202412:20 pmRNSDirector/PDMR Shareholding
5th Feb 202412:15 pmRNSDirector/PDMR Shareholding
2nd Feb 202412:00 pmRNSBAT and PMI Announce Global Patent Settlement
1st Feb 202412:45 pmRNSTotal Voting Rights
15th Jan 20242:00 pmRNSDirector/PDMR Shareholding
4th Jan 202412:30 pmRNSDirector/PDMR Shareholding
2nd Jan 202411:10 amRNSBlock listing Interim Review
2nd Jan 202410:15 amRNSTotal Voting Rights
19th Dec 20234:45 pmRNSHolding(s) in Company
12th Dec 20237:00 amRNSBranch Register: Dividend Finalisation Information
11th Dec 202310:35 amRNSHolding(s) in Company
11th Dec 202310:30 amRNSDirector/PDMR Shareholding
7th Dec 20233:30 pmRNSDirector/PDMR Shareholding
7th Dec 20233:30 pmRNSDirector/PDMR Shareholding
6th Dec 20237:55 amRNSPre-Close Trading Update and Strategy Update
6th Dec 20237:00 amRNSPre-Close Trading Update and Strategy Update
4th Dec 202311:30 amRNSTotal Voting Rights
4th Dec 20239:24 amRNSDirectorate Change
24th Nov 20232:30 pmRNSDirector/PDMR Shareholding
13th Nov 20233:00 pmRNSDirector/PDMR Shareholding
13th Nov 20232:15 pmRNSDirector/PDMR Shareholding
8th Nov 20239:55 amRNSDirector/PDMR Shareholding
8th Nov 20239:50 amRNSDirector/PDMR Shareholding
8th Nov 20239:45 amRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.